Balance Sheet Eurofins Scientific SE

Stocks

ERF

FR0014000MR3

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 12:40:16 18/06/2026 BST			5-day change	1st Jan Change
61.70 ^EUR	-1.34%		-4.10%	-1.12%

06-04	Eurofins Scientific SE acquired High North Laboratories.	CI
05-14	Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection	CI

0908c434362197f6.D4X0kt_sl5Ipg6hMcQZtkuN1HXuVhDZ5LnuCa58r5uM.X9az1bnfxcVaz8ELQDMl3owhSBXn1AErYin1D_l8qYhByr30ra_jo0Dm2w

Published financial data: EUROFINS SCIENTIFIC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	6.72B	6.71B	6.51B	6.95B	7.3B
Total Revenues	6.72B	6.71B	6.51B	6.95B	7.3B
Cost of Goods Sold, Total	4.8B	5.19B	5.14B	5.39B	5.66B
Gross Profit	1.91B	1.53B	1.37B	1.56B	1.64B
Selling General & Admin Expenses, Total	12.8M	14.2M	13.1M	10.5M	2.1M
Stock-Based Compensation (IS)	120M	127M	123M	116M	113M
Depreciation & Amortization - (IS)	429M	476M	522M	535M	562M
Other Operating Expenses, Total	562M	618M	658M	662M	677M
Operating Income	1.35B	909M	717M	898M	964M
Interest Expense, Total	-94.3M	-91.6M	-123M	-146M	-154M
Net Interest Expenses	-94.3M	-91.6M	-123M	-146M	-154M
Income (Loss) On Equity Invest.	2M	900K	400K	1M	300K
Currency Exchange Gains (Loss)	-17.9M	-32.9M	11.2M	4.9M	24.6M
Other Non Operating Income (Expenses)	1.8M	-11.6M	7.2M	17.1M	700K
EBT, Excl. Unusual Items	1.24B	774M	612M	774M	835M
Restructuring Charges	-32.2M	-	-	-	-68.1M
Merger & Related Restructuring Charges	-13.6M	-8.7M	-15.1M	-24.1M	-25.5M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	141M	-1.8M	-23.6M	-8.9M
Other Unusual Items	-142M	-126M	-172M	-172M	-78.8M
EBT, Incl. Unusual Items	1.06B	780M	423M	555M	654M
Income Tax Expense	274M	174M	116M	149M	181M
Earnings From Continuing Operations	783M	606M	308M	406M	473M
Net Income to Company	783M	606M	308M	406M	473M
Minority Interest	-400K	4.4M	2.5M	900K	1.8M
Net Income - (IS)	783M	610M	310M	406M	475M
Preferred Dividend and Other Adjustments	34.1M	29.3M	53.7M	50.1M	58.7M
Net Income to Common Incl Extra Items	748M	581M	256M	356M	416M
Net Income to Common Excl. Extra Items	748M	581M	256M	356M	416M
Per Share Items
Net EPS - Basic	3.91	3.02	1.33	1.87	2.31
Basic EPS - Continuing Operations	3.91	3.02	1.33	1.87	2.31
Basic Weighted Average Shares Outstanding	192M	192M	193M	191M	180M
Net EPS - Diluted	3.73	2.92	1.3	1.83	2.23
Diluted EPS - Continuing Operations	3.73	2.92	1.3	1.83	2.23
Diluted Weighted Average Shares Outstanding	201M	199M	198M	194M	186M
Normalized Basic EPS	4.06	2.53	2	2.54	2.91
Normalized Diluted EPS	3.87	2.45	1.95	2.49	2.81
Dividend Per Share	1	1	0.5	0.6	0.72
Payout Ratio	21.22	37.36	75.4	36.69	33.15
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	1.75B	1.35B	1.19B	1.37B	1.46B
EBITA	1.45B	1.01B	816M	992M	1.06B
EBIT	1.35B	909M	717M	898M	964M
EBITDAR	1.76B	1.37B	1.2B	1.37B	-
Effective Tax Rate - (Ratio)	25.89	22.33	27.29	26.88	27.69
Total Current Taxes	300M	201M	157M	185M	164M
Total Deferred Taxes	-26.3M	-27M	-41.4M	-35.9M	16.6M
Normalized Net Income	777M	488M	385M	485M	524M
Interest on Long-Term Debt	72.7M	76.3M	106M	122M	125M
Non-Cash Pension Expense	500K	400K	2.2M	2.1M	2.1M
Supplemental Operating Expense Items
Net Rental Expense, Total	12.1M	13.4M	11M	8M	-
Imputed Operating Lease Interest Expense	3.09M	3.23M	2.99M	2.49M	-
Imputed Operating Lease Depreciation	9.01M	10.17M	8.01M	5.51M	-
Stock-Based Comp., Other (Total)	120M	127M	123M	116M	113M
Total Stock-Based Compensation	120M	127M	123M	116M	113M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	515M	487M	1.22B	614M	791M
Trading Asset Securities, Total	500K	5.6M	4.3M	2M	3M
Total Cash And Short Term Investments	516M	492M	1.23B	616M	794M
Accounts Receivable, Total	1.39B	1.34B	1.38B	1.4B	1.42B
Other Receivables	192M	256M	236M	208M	223M
Total Receivables	1.58B	1.6B	1.62B	1.61B	1.64B
Inventory	154M	146M	139M	142M	139M
Prepaid Expenses	68M	78.3M	84.9M	85.7M	76.1M
Other Current Assets, Total	-	-100K	-	-100K	-
Total Current Assets	2.32B	2.31B	3.07B	2.45B	2.65B
Gross Property Plant And Equipment	4.02B	4.74B	4.92B	5.44B	5.78B
Accumulated Depreciation	-2.19B	-2.57B	-2.62B	-2.88B	-3.02B
Net Property Plant And Equipment	1.83B	2.17B	2.3B	2.56B	2.76B
Long-term Investments	81.7M	83.6M	83.6M	117M	106M
Goodwill	4.12B	4.52B	4.55B	4.84B	4.66B
Other Intangibles, Total	896M	919M	796M	788M	690M
Deferred Tax Assets Long-Term	90.9M	75.7M	93.8M	130M	116M
Other Long-Term Assets, Total	-	-	-	200K	-
Total Assets	9.33B	10.08B	10.89B	10.89B	10.99B
Liabilities
Accounts Payable, Total	323M	347M	339M	376M	399M
Accrued Expenses, Total	860M	836M	823M	868M	907M
Short-term Borrowings	80.3M	78.5M	300K	83.1M	247M
Current Portion of Long-Term Debt	52.8M	6.7M	458M	246M	342M
Current Portion of Leases	121M	129M	143M	150M	138M
Current Income Taxes Payable	86M	34.7M	26.7M	35.5M	29.8M
Unearned Revenue Current, Total	163M	184M	193M	196M	217M
Other Current Liabilities	170M	156M	139M	156M	150M
Total Current Liabilities	1.86B	1.77B	2.12B	2.11B	2.43B
Long-Term Debt	2.08B	2.71B	2.89B	2.67B	3.41B
Long-Term Leases	418M	399M	436M	457M	298M
Pension & Other Post Retirement Benefits	75.5M	59.5M	66.2M	66.4M	64.2M
Deferred Tax Liability Non Current	124M	134M	110M	110M	121M
Other Non Current Liabilities	100M	155M	128M	86M	88.5M
Total Liabilities	4.66B	5.23B	5.75B	5.5B	6.41B
Common Stock, Total	1.9M	1.9M	1.9M	1.9M	1.8M
Retained Earnings	1.96B	2.33B	2.39B	2.69B	3.02B
Treasury Stock	-3.6M	-14.2M	-54.9M	-308M	-299M
Comprehensive Income and Other	2.68B	2.46B	2.74B	2.95B	1.82B
Total Common Equity	4.65B	4.78B	5.08B	5.34B	4.54B
Minority Interest	29.5M	68.9M	59.9M	45.8M	33.4M
Total Equity	4.68B	4.85B	5.14B	5.38B	4.58B
Total Liabilities And Equity	9.33B	10.08B	10.89B	10.89B	10.99B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	192M	193M	193M	187M	177M
ECS Total Common Shares Outstanding	192M	193M	193M	187M	177M
Book Value / Share	18.98	21.8	21.14	23.23	20.05
Tangible Book Value	-363M	-661M	-270M	-290M	-804M
Tangible Book Value Per Share	-7.09	-6.46	-6.58	-6.9	-10.21
Total Debt	2.75B	3.33B	3.93B	3.61B	4.43B
Net Debt	2.24B	2.83B	2.7B	2.99B	3.64B
Debt Equivalent of Unfunded Proj. Benefit Obligation	75.6M	59.5M	66.3M	66.4M	64.2M
Debt Equivalent Oper. Leases	96.8M	107M	88M	64M	-
Minority Interest, Total (Incl. Fin. Div)	29.5M	68.9M	59.9M	45.8M	33.4M
Equity Method Investments, Total	6.2M	5.2M	5.3M	5.9M	5.3M
Account Code - Inventory Valuation	5	5	5	-	5
Inventories - Others	193M	174M	157M	157M	150M
Land - (BS)	994M	1.28B	1.45B	-	2.19B
Machinery, Total	1.94B	2.27B	2.38B	4.35B	2.63B
Full Time Employees	57.99K	61.38K	61.8K	62.7K	65.69K
Accumulated Allowance for Doubtful Accounts (Supple)	55.1M	57.9M	63.3M	60.5M	58.9M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	783M	610M	310M	406M	475M
Depreciation & Amortization - CF	429M	476M	522M	538M	561M
Amortization of Goodwill and Intangible Assets - (CF)	97.6M	104M	99.3M	94.7M	93.4M
Depreciation & Amortization, Total	526M	580M	621M	633M	655M
Amortization of Deferred Charges, Total - (CF)	7.3M	3.8M	4.7M	4.8M	4.6M
(Gain) Loss From Sale Of Asset	100K	-141M	1.8M	23.6M	8.9M
Asset Writedown & Restructuring Costs	21.9M	41.7M	72.8M	76M	77.4M
(Income) Loss On Equity Investments - (CF)	-2M	-900K	-400K	-1M	-300K
Stock-Based Compensation (CF)	22.2M	22.9M	23.3M	21.8M	19.8M
Other Operating Activities, Total	157M	-11.7M	49M	111M	108M
Change In Accounts Receivable	-196M	47.5M	-43.4M	37.2M	-44.5M
Change In Inventories	2.8M	8.6M	11M	3.6M	1.4M
Change In Accounts Payable	85.6M	20.1M	-41.3M	-25.9M	25M
Change in Unearned Revenues	26.3M	21.1M	10.2M	-3M	26.3M
Change In Deferred Taxes	-6.3M	-7.5M	-	-	-
Change in Other Net Operating Assets	82M	-58.6M	-1.3M	32M	42.9M
Cash from Operations	1.51B	1.14B	1.02B	1.32B	1.4B
Capital Expenditure	-458M	-576M	-478M	-454M	-760M
Sale of Property, Plant, and Equipment	24.8M	14.9M	6.4M	10.2M	14.2M
Cash Acquisitions	-533M	-430M	-158M	-343M	-261M
Divestitures	-	215M	7.3M	-900K	-2.8M
Sale (Purchase) of Intangible assets	-62M	-84.1M	-72M	-74.8M	-74.9M
Investment in Marketable and Equity Securities, Total	-8.4M	1.5M	1.9M	-3.3M	-2M
Other Investing Activities, Total	1.6M	2.6M	11.5M	19.3M	10.6M
Cash from Investing	-1.03B	-856M	-681M	-846M	-1.08B
Long-Term Debt Issued, Total	826M	634M	638M	118M	1.22B
Total Debt Issued	826M	634M	638M	118M	1.22B
Long-Term Debt Repaid, Total	-1.43B	-249M	-270M	-670M	-505M
Total Debt Repaid	-1.43B	-249M	-270M	-670M	-505M
Issuance of Common Stock	35.8M	14.6M	602M	200K	397M
Repurchase of Common Stock	-3.6M	-433M	-238M	-272M	-940M
Common Dividends Paid	-166M	-228M	-234M	-149M	-157M
Common & Preferred Stock Dividends Paid	-166M	-228M	-234M	-149M	-157M
Other Financing Activities, Total	-169M	-49.7M	-83.5M	-117M	-118M
Cash from Financing	-910M	-311M	414M	-1.09B	-102M
Foreign Exchange Rate Adjustments	39.1M	-800K	-12.7M	9.4M	-46.6M
Miscellaneous Cash Flow Adjustments	100K	-100K	100K	-	100K
Net Change in Cash	-396M	-31.8M	738M	-608M	175M
Supplemental Items
Cash Interest Paid	169M	49.4M	82.2M	114M	116M
Cash Income Tax Paid (Refund)	297M	296M	140M	161M	189M
Levered Free Cash Flow	866M	501M	512M	811M	493M
Unlevered Free Cash Flow	918M	554M	584M	897M	584M
Change In Net Working Capital	54.3M	61.4M	57.6M	-115M	-48.5M
Net Debt Issued / Repaid	-607M	385M	368M	-552M	717M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.44	5.85	4.27	5.15	5.51
Return on Total Capital	11.82	7.28	5.2	6.21	6.69
Return On Equity %	18.66	12.72	6.16	7.71	9.5
Return on Common Equity	17.95	12.32	5.2	6.84	8.42
Margin Analysis
Gross Profit Margin %	28.49	22.74	21.1	22.45	22.49
SG&A Margin	0.19	0.21	0.2	0.15	0.03
EBITDA Margin %	26.02	20.15	18.22	19.66	19.94
EBITA Margin %	21.58	15.1	12.53	14.28	14.49
EBIT Margin %	20.13	13.54	11.01	12.92	13.21
Income From Continuing Operations Margin %	11.66	9.03	4.72	5.83	6.48
Net Income Margin %	11.65	9.09	4.76	5.85	6.51
Net Avail. For Common Margin %	11.14	8.65	3.94	5.13	5.7
Normalized Net Income Margin	11.57	7.27	5.91	6.98	7.18
Levered Free Cash Flow Margin	12.89	7.46	7.86	11.66	6.75
Unlevered Free Cash Flow Margin	13.66	8.26	8.97	12.91	8.01
Asset Turnover
Asset Turnover	0.75	0.69	0.62	0.64	0.67
Fixed Assets Turnover	3.95	3.36	2.92	2.86	2.74
Receivables Turnover (Average Receivables)	5.2	4.92	4.79	5	5.17
Inventory Turnover (Average Inventory)	30.87	34.6	36.12	38.38	40.22
Short Term Liquidity
Current Ratio	1.25	1.31	1.45	1.16	1.09
Quick Ratio	1.13	1.18	1.34	1.05	1
Operating Cash Flow to Current Liabilities	0.81	0.64	0.48	0.63	0.58
Days Sales Outstanding (Average Receivables)	70.16	74.25	76.26	73.22	70.58
Days Outstanding Inventory (Average Inventory)	11.82	10.55	10.11	9.54	9.07
Average Days Payable Outstanding	22.87	23.63	24.41	24.26	25.01
Cash Conversion Cycle (Average Days)	59.11	61.17	61.95	58.49	54.65
Long Term Solvency
Total Debt/Equity	58.88	68.55	76.43	67.05	96.84
Total Debt / Total Capital	37.06	40.67	43.32	40.14	49.2
LT Debt/Equity	53.46	64.15	64.73	58.15	80.96
Long-Term Debt / Total Capital	33.65	38.06	36.69	34.81	41.13
Total Liabilities / Total Assets	49.88	51.89	52.82	50.55	58.34
EBIT / Interest Expense	14.34	9.92	5.81	6.13	6.26
EBITDA / Interest Expense	19.92	16.26	10.85	10.45	10.52
(EBITDA - Capex) / Interest Expense	15.07	9.97	6.97	7.35	5.58
Total Debt / EBITDA	1.47	2.23	2.93	2.36	2.74
Net Debt / EBITDA	1.19	1.9	2.02	1.96	2.25
Total Debt / (EBITDA - Capex)	1.94	3.64	4.56	3.35	5.16
Net Debt / (EBITDA - Capex)	1.57	3.1	3.14	2.78	4.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.51	-0.08	-2.94	6.7	4.96
Gross Profit, 1 Yr. Growth %	35.47	-19.74	-9.13	14.41	5.71
EBITDA, 1 Yr. Growth %	37.19	-22.63	-12.23	15.15	6.46
EBITA, 1 Yr. Growth %	43.95	-30.12	-19.43	21.59	6.51
EBIT, 1 Yr. Growth %	49.52	-33.09	-21.1	25.22	7.34
Earnings From Cont. Operations, 1 Yr. Growth %	44.89	-22.63	-49.21	31.78	16.65
Net Income, 1 Yr. Growth %	45.09	-22.03	-49.16	31.01	16.83
Normalized Net Income, 1 Yr. Growth %	55.93	-37.51	-21.03	25.85	8.06
Diluted EPS Before Extra, 1 Yr. Growth %	44.57	-21.72	-55.48	40.77	21.86
Accounts Receivable, 1 Yr. Growth %	16.4	-3.42	2.89	1.45	1.49
Inventory, 1 Yr. Growth %	-1.78	-5.58	-4.53	2.09	-1.83
Net Property, Plant and Equip., 1 Yr. Growth %	16.19	18.46	5.98	11.42	7.93
Total Assets, 1 Yr. Growth %	8.83	8.05	7.98	-0	0.89
Tangible Book Value, 1 Yr. Growth %	-44.88	82.02	-59.17	7.26	177.65
Common Equity, 1 Yr. Growth %	25.94	2.89	6.18	5.15	-14.9
Cash From Operations, 1 Yr. Growth %	23.4	-24.82	-10.42	29.57	6.07
Capital Expenditures, 1 Yr. Growth %	47.2	29.64	-17.01	-5.12	67.53
Levered Free Cash Flow, 1 Yr. Growth %	9.2	-42.8	2.22	58.34	-39.24
Unlevered Free Cash Flow, 1 Yr. Growth %	7.54	-39.94	5.43	53.57	-34.91
Dividend Per Share, 1 Yr. Growth %	47.06	0	-50	20	20
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.34	11.09	-1.52	1.76	5.83
Gross Profit, 2 Yr. CAGR %	43.39	3.94	-14.98	1.55	9.69
EBITDA, 2 Yr. CAGR %	48.28	3.03	-17.59	0.53	10.72
EBITA, 2 Yr. CAGR %	61.43	0.3	-24.97	-1.03	13.8
EBIT, 2 Yr. CAGR %	72.13	0.24	-27.34	-0.6	15.93
Earnings From Cont. Operations, 2 Yr. CAGR %	100.28	5.88	-37.31	-18.19	23.98
Net Income, 2 Yr. CAGR %	100.23	6.36	-37.04	-18.39	23.72
Normalized Net Income, 2 Yr. CAGR %	85.25	-1.06	-29.75	-0.31	16.62
Diluted EPS Before Extra, 2 Yr. CAGR %	118.68	6.39	-40.96	-20.83	30.97
Accounts Receivable, 2 Yr. CAGR %	17.79	6.03	-0.31	2.17	1.47
Inventory, 2 Yr. CAGR %	39.45	-3.7	-5.06	-1.28	0.11
Net Property, Plant and Equip., 2 Yr. CAGR %	7.16	17.32	12.05	8.67	9.66
Total Assets, 2 Yr. CAGR %	9.22	8.44	8.02	3.91	0.44
Tangible Book Value, 2 Yr. CAGR %	-53.62	0.17	-13.8	-33.83	72.57
Common Equity, 2 Yr. CAGR %	27.96	13.84	4.52	5.66	-5.41
Cash From Operations, 2 Yr. CAGR %	49.24	-3.63	-17.93	7.74	17.23
Capital Expenditures, 2 Yr. CAGR %	28.24	36.15	3.72	-11.27	26.07
Levered Free Cash Flow, 2 Yr. CAGR %	40.93	-20.54	-23.53	27.22	-1.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	36.29	-19.41	-20.43	27.24	-0.02
Dividend Per Share, 2 Yr. CAGR %	70.25	21.27	-29.29	-22.54	20
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.12	13.73	6.2	1.14	2.82
Gross Profit, 3 Yr. CAGR %	38.54	17.92	-0.9	-6.38	2.74
EBITDA, 3 Yr. CAGR %	35.18	19.38	-2.33	-7.87	2.47
EBITA, 3 Yr. CAGR %	41.79	22.12	-6.77	-11.87	1.42
EBIT, 3 Yr. CAGR %	46.42	25.8	-7.45	-12.89	1.98
Earnings From Cont. Operations, 3 Yr. CAGR %	51.88	45.86	-17.12	-19.7	-7.92
Net Income, 3 Yr. CAGR %	51.76	46.22	-16.84	-19.62	-8.02
Normalized Net Income, 3 Yr. CAGR %	48.71	29.15	-8.22	-14.68	2.41
Diluted EPS Before Extra, 3 Yr. CAGR %	57.32	55.27	-20.43	-21.13	-8.59
Accounts Receivable, 3 Yr. CAGR %	17.11	10.25	4.97	0.27	1.94
Inventory, 3 Yr. CAGR %	32.43	22.45	-3.98	-2.73	-1.46
Net Property, Plant and Equip., 3 Yr. CAGR %	21.59	10.8	13.41	11.84	8.42
Total Assets, 3 Yr. CAGR %	9	8.83	8.29	5.28	2.9
Tangible Book Value, 3 Yr. CAGR %	-40.17	-26.84	-25.73	-7.28	6.73
Common Equity, 3 Yr. CAGR %	20.3	18.99	11.22	4.73	-1.69
Cash From Operations, 3 Yr. CAGR %	40.54	18.79	-5.95	-4.44	7.18
Capital Expenditures, 3 Yr. CAGR %	12.4	27.46	15.44	0.69	9.67
Levered Free Cash Flow, 3 Yr. CAGR %	61.96	4.72	-13.58	-2.54	-0.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	56.07	3.91	-11.86	-0.93	1.77
Dividend Per Share, 3 Yr. CAGR %	51.43	42.58	-9.74	-15.66	-10.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.5	17.7	11.49	8.78	6.05
Gross Profit, 5 Yr. CAGR %	31.89	22.35	13.82	10.88	3.04
EBITDA, 5 Yr. CAGR %	29.91	19.75	10.9	11.45	2.69
EBITA, 5 Yr. CAGR %	32.85	20.92	9.92	12.27	0.97
EBIT, 5 Yr. CAGR %	33.47	20.94	10.73	14.49	1.28
Earnings From Cont. Operations, 5 Yr. CAGR %	34.56	22.59	6.6	15.74	-2.63
Net Income, 5 Yr. CAGR %	35.08	23	6.74	15.8	-2.52
Normalized Net Income, 5 Yr. CAGR %	35.19	20.91	10.27	16.45	1.01
Diluted EPS Before Extra, 5 Yr. CAGR %	35.52	23.98	6.3	18.6	-2.87
Accounts Receivable, 5 Yr. CAGR %	21.51	13.71	9.8	6.94	3.56
Inventory, 5 Yr. CAGR %	31.28	22.96	15.92	12.34	-2.36
Net Property, Plant and Equip., 5 Yr. CAGR %	29.28	25.87	17.68	9.94	11.9
Total Assets, 5 Yr. CAGR %	17.71	11.57	8.61	6.84	5.08
Tangible Book Value, 5 Yr. CAGR %	1.31	-3.68	-30.76	-29.72	4.06
Common Equity, 5 Yr. CAGR %	23.35	14.38	13.72	13.47	4.25
Cash From Operations, 5 Yr. CAGR %	32.35	22.91	13.35	14.24	2.72
Capital Expenditures, 5 Yr. CAGR %	24.05	23.48	8.21	10.27	19.58
Levered Free Cash Flow, 5 Yr. CAGR %	45.41	24.54	20.22	13.2	-9.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	39.43	22.92	19.34	12.68	-7.3
Dividend Per Share, 5 Yr. CAGR %	37.97	33.03	11.66	11.7	1.15